New Foot-and-Mouth Disease Vaccine Developed by South Korean Company
South Korean biotechnology company Optipharm is developing vaccines to reduce the country’s reliance on imported biological products. The company is also researching the use of genetically modified pig organs for human transplantation. The two projects use different technologies and target different problems. Optipharm is developing vaccines using virus-like particles, or VLPs, while its transplant research […]